D-0264-2025 Class II Ongoing
FDA drug recall D-0264-2025 was initiated by Aspen Biopharma Labs Pvt., Ltd. on Feb 7, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 150.0 gm.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 19, 2025
- Initiation Date
- Feb 7, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 150.0 gm
Product description
Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle
Reason for recall
CGMP Deviations
Distribution pattern
Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
Code information
Lot Numbers: HALAC0010123, exp. date Dec-2026 HALAC0050923, exp. date Aug-2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0264-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026